January 7, 2023 “You’re going to have a sword of Damocles above any speaker over any actual or perceived dalliance with bipartisanship,” said Stewart Verdery, a former GOP Senate aide […]
Joel White spoke with Inside Drug Pricing about the Biden Adminstration’s growing interest in value-based payments for prescription drugs. CMS’ Center for Medicare and Medicaid Innovation (CMMI) is considering testing […]
Horizon CEO, Joel White, spoke to Inside Health Policy about how the Inflation Reduction Act’s drug pricing negotiations will impact the pharmaceutical industry. Horizon Government Affairs President and Founder Joel […]
Monument Keeping an eye on SCOTUS January 23, 2023 KEEPING AN EYE ON SCOTUS: The Supreme Court will take up cases on several hot-button social issues this year, and though some […]
Horizon’s Brett Meeks spoke with Inside Telehealth about the recent two-year telehealth extension for standalone plans. But Brett Meeks, vice president at Horizon Government Affairs, said for now lobbyists can […]
The National Review included Horizon’s work tracking drugmakers responses to the Inflation Reduction Act’s drug pricing negotiation rule, in a recent article titled, “As Predicted, Patients Are Paying the Price […]
Horizon Government Affairs is pleased to introduce Horizon Highlights. Every month, the Horizon policy team will focus on one timely topic, breaking it down into easy-to-understand infographics.
Horizon Government Affairs President Joel White led a post-election webinar to discuss the results (as of November 10th) of the 2022 midterms and insights into how Congress might address health […]
Horizon Government Affairs prepared the report linked below on key races in the 2022 midterm election and where candidates stand on health policies.
Horizon hosted a webinar for clients and friends on September 12, 2022 reviewing the Inflation Reduction Act, exploring the prescription drug provisions of the law, its implications, pitfalls and next […]